Vol. XXXIX, no. 1, 2012 ISSN: 0390-6663


CLINICAL AND EXPERIMENTAL
OBSTETRICS & GYNECOLOGY

an International Journal


Founding Editor
A. Onnis
Montréal (CND)


Editors-in-Chief
M. Marchetti
Montréal (CND)
J.H. Check
Camden, NJ (USA)


Assistant Editor
J. Wilson
San Diego - CA (USA)
Editorial Board
Audet-Lapointe P., Montréal (Canada)
Axt-Fliedner R., Lübeck (Germany)
Basta A., Krakow (Poland)
Bender H.J., Dusseldorf (Germany)
Bhattacharya N., Calcutta (India)
Bonilla Musoles F., Valencia (Spain)
Charkviani T., Tbilisi (Georgia)
Dexeus S., Barcelona (Spain)
Di Paola G., Buenos Aires (Argentina)
Eskes T.K.A.B.,
Nijmegen (The Netherlands)
Farghaly S.A., New York (USA)
Friedrich M., Homburg (Germany)
Gomel V., Vancouver (Canada)
Gorins A., Paris (France)
Grella P.V., Padua (Italy)
Holub Z., Kladno (Czech Republic)
Jordan J.A., Birmingham, England (UK)
Kaplan B., Petach Tikva (Israel)
Kralj B., Ljubljana (Slovenia)
Markowska J., Poznan (Poland)
Marth C., Innsbruck (Austria)
Meden-Vrtovec H., Ljubljana (Slovenia)
Murta E.F.C., Uberaba (Brasil)
Papadopoulos N., Alexandroupolis (Greece)
Rakar S., Ljubljana (Slovenia)
Sciarra J.J., Chicago, IL (USA)
Stelmachow J., Warsaw (Poland)
Varras M.N., Athens (Greece)
Winter R., Graz (Austria)

Publishing Organization (M. Morsani):
I.R.O.G. CANADA, Inc. - 4900 Côte St-Luc - Apt # 212 - Montréal, Qué. H3W 2H3 (Canada)
Tel. +514-4893242 - Fax +514-4854513 - E-mail: canlux@mgroup-online.com - http://www.irog.net/

Editorial Office (M. Critelli):
Galleria Storione, 2/A - 35123 Padua (Italy) - Tel. (39) 049 8756900 - Fax (39) 049 8752018

CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes original work, preferably brief reports, in the fields of Gynecology, Obstetrics, Fetal Medicine, Gynecological Endocrinology and related subjects. (Fertility and Sterility, Menopause, Uro-gynecology, Ultrasound in Obstetrics and Gynecology, Sexually Transmitted Diseases).The Journal is covered by INDEX MEDICUS, MEDLINE, EMBASE/Excerpta Medica.

CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY is issued every three months in one volume per year by IROG CANADA Inc. Montréal. Printed in Italy by "La Garangola", Tipografia Editrice - Via E. Dalla Costa, 6 -35129 Padova (Italy).

 

Clinical and Experimental Obstetrics and Gynecology
http://www.irog.net/


General Information

CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes original peer-reviewed work, preferably brief reports, in the fields of Gynecology, Obstetrics, Fetal Medicine, Gynecological Endocrinology, Fertility and Sterility, Menopause, Uro-gynecology, Ultrasound diagnosis in Obstetrics and Gynecology, Sexually transmitted diseases and related topics. It is indexed in INDEX MEDICUS, MEDLINE, EMBASE/ Excerpta Medica.

AIMS AND SCOPE
Since its inception, the CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY Journal has had the primary aim to assemble and diffuse scientific researches, particularly original researches, contributions, reviews, and proceedings of meetings in every field of the Discipline.
Today its large diffusion all over the world allows us to collect high quality papers and clinical reports on many interesting studies from every country, even from developing countries. This is the target goal of the Journal – aiming at the diffusion of knowledge and advances in female genital diseases.
This publication tries to cover all aspects of obstetrics and gynecology in an interdisciplinary approach among gynecologists, epidemiologists, pathologists, oncologists, radiologists, microbiologists, surgeons, urologists, neonatologists, genetists and so on.
The first target goal of the Journal is to publish high quality papers in the shortest time possible. Research papers, editorial reviews, case reports, technical notes, book reviews and letters to the Editor are published.

ANNOUNCEMENTS regarding meetings, postgraduate courses and symposia will be accepted 6 months before publication and will be published free of charge.
BOOK SAMPLES for review should be sent to the Editorial offices in Montréal or in Padova.
COPYRIGHT: the Journal has been registered with the Copyright Clearance Center, Inc. Reproductions are not allowed without the written consent of the Publisher. All photocopy fees should be paid to the Copyright Clearance Center, Inc., 21 Congress Street, Salem, MA 01970, USA stating the ISSN number, the volume and the first and last page numbers of each article copied.
ADVERTISING INFORMATION: advertising orders and inquiries may be sent to: I.R.O.G. CANADA Inc., Publisher, 4900 Côte St. Luc, Apt. 212, Montréal (Quebec) Canada H3W 2HS, Tél. 514.4893242-4893640 - Fax 514.4854513 - E-mail: canlux@mgroup-online.com - www.irog.net
RESPONSIBILITY: although every effort is made by the editorial staff and the printer to eliminate misleading or inaccurate information, the publisher accepts no responsibility for the consequences of faultful or incorrect information. The authors recognize that the editor and publisher have no responsibility and are indemnified against any liability or claim that may result from the publication of misleading or incorrect data.

SUBSCRIPTION INFORMATION
The Journal is issued every three months (January, April, July and October); one volume per year. Subscriptions start from January and are automatically renewed if not cancelled by the end of September.
Subscriptions include four issues per year plus supplements and monographs and all official communications of Meetings, Courses, Symposia and all scientific activities in the fields of Obstetrics and Gynecology and related topics.
Subscriptions are entered with prepayment only. The annual subscription is $280 US for Institutions and $170 US for Individuals all over the world. For air mail add $20. Single copies prepaid cost $75.00 US.
Send subscription requests with cheque or credit card payment (Amex - Visa - Diners - Master Card) to I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt. 212, Montréal, Québec H3W 2H3, Canada. Only US Funds are accepted.
Claims for missing issues can be honored up to six months. Changes of address: allow six weeks for all changes to become effective. All communications should include both old and new addresses (with postal codes) - better if accompanied by a mailing label from a recent issue and should be sent to the printer La Garangola, Via E. Dalla Costa, 6 - 35129 Padova (Italy) - also by Tel. +39.049.8075557, Fax +39.049.7806580. Claims should be made within six months of publication date. Duplicate copies will not be sent to replace those undelivered through failure to notify of change of address.
Single copies and back issue and volume information is available from the printer La Garangola, Padua, Tel. +39.049.8075557, Fax +39.049.7806580. Certain back issues may only be available as photocopies of the originals.
All other business correspondence including orders for offprints and advertising space and any communication and requests should be addressed to I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt. 212, MONTRÉAL, QUÉBEC H3W 2H3 (Canada), Tel. (514) 4893242, fax (514) 4854513.

IN ALL LEGAL MATTERS THE COURT OF MONTREAL IS COMPETENT.




Instructions to Authors

SUBMISSION OF MANUSCRIPTS
Papers should be submitted to A. ONNIS Editor-in-Chief of the EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 4900 Côte St. Luc, Apt. 212 MONTREAL, QUÉBEC H3W 2H3 (Canada) - Tel. +514-4893242 - Fax +514-4854513, or Galleria Sto-rione 2/A - 35123 PADOVA (Italy) - Fax +39-049-8752018.

Editorial articles for publication in the "Distinguished Expert Series" should be submitted to P. Bösze, Editor-in-Chief of this section, Department of Gynecology, Saint Stephan Hospital, 1096 Budapest, Nagyvárad tér 1, Telephone (36-1) 275 2172, Fax (36-1)
275 2172, E-mail: bosze@axelero.hu

When a manuscript is submitted, an acknowledgement card is sent to the corresponding author within two or three weeks.

Submitted papers are reviewed by the Editor-in-Chief and his Peer Referees. Authors may be required to modify the manuscript according to the reviewers' suggestions.

Manuscripts accepted for publication will be copyedited by the editorial staff for typographical and grammatical mistakes and to guarantee clarity and conciseness.

Publication time will be the shortest possible based on scientific and publishing needs. Manuscripts submitted for publi-cation cannot be returned.

Published papers will become property of the Journal and copyrighted under I.R.O.G. CANADA Inc.

After six months no grievances will be accepted regarding published articles.

All statements are the responsibility of the authors. Product dosages, indications and methods referred to in the papers reflect the author's experience. No responsibility is assumed by the Editor-in-Chief or the Publisher for any damage from use of any products, operation methods or instructions contained in the published materials.

Trade names, trademarks, etc. are protected by the law and regulations. The Editor-in-Chief and the Publisher cannot accept any legal responsibility for any errors or omissions that may be made in press, particularly for information about drug dosage and appli-cation thereof contained in the Journal. Consult the prescribing information before administering any drug.

MANUSCRIPT REQUIREMENTS
The Journal follows the "Uniform requirements for manuscripts submitted to biomedical journals" published in the New England Journal of Medicine 1991, 324, 424-8 and in the British Medical Journal 1991, 302.

Three manuscripts, typed and double spaced should be submitted with an electronic disk, formatted in Word for Macintosh or Windows, version 6.0. Manuscripts without an electronic disk will not be accepted. A cover letter signed by all authors must state that all authors who have participated in the work take responsibility for the manuscript which has never been pub lished or submitted for publication elsewhere. Without a cover letter the publication will not be possible. Name, address and phone/fax numbers of the Corresponding Author, responsible for revision and approval of the proofs, should be indicated. Full-length articles should not exceed 8 printed pages including tables and references.

After the title page (full title and names of authors, institutions, eventual acknowledgement for financial support, running title of no more than 60 characters or spaces), original works should be arranged in the conventional order: Summary (purpose of investiga-tion, methods, results, conclusion - about 150 words), Key words, Content (a 20-word summary), Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgement (if any), References, Tables, Legends.

Authors should supply a complete address for reprint requests.

In the text only standard abbreviations can be used and must be avoided in the title. The full term for which an abbreviation stands should precede its first use in the summary and text unless it is a standard unit of measurement.

Authors must give their complete professional identifications and affiliations, including all academic titles and positions.

Letters to the editor should be brief (500 words or less) and offer objective, constructive and educational criticism of published material. The editor reserves the right to publish.

Figures: Two original copies (not negatives) of each figure are requested. Each figure should have a label on the back indicating its number, author's name and top of the figure. Do not write on the back of the figures and do not mount them on cardboard. If sending colour pictures advise if they must be printed in colour or black and white (colour costs ten times more).

Legends should be typed on a separate page with Arabic numerals corresponding to the illustrations.

Tables should be titled, typed in double space on separate pages and numbered in Arabic numerals in the order of their first cita-tion
in the text. Do not use internal rules. Only standard, universally understood abbreviations should be used.

References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in the text, tables, and legends by Arabic numerals in parentheses.

Use the style of the examples below, which are based with slight modifications on the format used by the U.S. National Library of Medicine in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus.

References must be verified by the Author(s) against the original documents.

Examples of correct forms of references are given below:

Articles in Journals: Authors' surname and initials (if more than six names, give six followed by "et al."), Title, Abbreviated Journal Title, Year of Publication, Volume, Issue and first page.

Books: Authors' surname and initials, title of the book and title of chapter, in: Title, Editor(s), Place, Publisher, Year, Page.

Acknowledgments
will be limited to appropriate professionals who were contributors to the paper.

PROOFS revised by the editorial staff will be sent to the corresponding author and should be checked and returned within ten days. The corresponding author is responsible for detecting typesetting errors. After this deadline the proofs will be considered approved. Only essential corrections should be made; extensive changes will be charged to the authors.

BUSINESS MATTERS
The Journal has no commercial advertisements.

Authors will be expected to contribute to the printing expenses, tables, figures and postage. For every published article a copy of the Journal will be provided free of charge. Only payments in US dollars will be accepted. No bank transfers.

Reprints should be requested with the form enclosed with the acceptance letter. No free reprints will be supplied.


© By I.R.O.G. CANADA INC. - Publisher - Editorial office 4900 Côte St. Luc - Apt. 212 - Montréal Québec H3W 2H3 (Canada) - Tel. (514) 4893242-4893640 -Fax (514) 4854513 - Printed in Italy by "La Garangola" - Via E. Dalla Costa, 6 - 35129 Padua (Italy) - Responsible Director: Prof. Antonio Onnis M.D. - Authorization of Padua's Court n. 633 - 28-6-1979
 
Clinical and Experimental Obstetrics & Gynecology - Vol. XXXIX, no. 1, 2012
   
EDITORIAL ARTICLES  
Physicians should be more open-minded about performing in vitro fertilization-embryo transfer in
women with diminished oocyte reserve and consider the couple’s wishes and desires
5
J.H. Check - Camden, NJ (USA)
Pregnancies despite very diminished oocyte reserve are possible with IVF-ET and patient wishes should be heavily considered
in therapeutic decisions.
 
 
ORIGINAL ARTICLES  
Reproductive Biology Section  
“Embryo glue” does not seem to improve chances of subsequent pregnancy in refractory in vitro
fertilization cases
11
J.H. Check, D. Summers-Chase, W. Yuan, K. Swenson, D. Horwath, M. Press - Camden, NJ (USA)
A matched control study failed to demonstrate any benefit of using “embryo glue” to allow better implantation in refractory
IVF cases.
 
Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral
follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure
13
F. Bonilla-Musoles, J.C. Castillo, O. Caballero, J. Pérez-Panades, F. Bonilla Jr., M. Dolz, N. Osborne -
Valencia, SPAIN
AMH levels and AFC are reliable indicators of ovarian reserve. Patients with ovarian reserve levels that predict a very low
probability of success should be informed about the poor prognosis.
 
Frequency of subnormal hypoosmotic swelling tests increase with advancing age of the male 19
J.H. Check, D. Kramer, A. Bollendorf, C. Wilson - Camden, NJ (USA)
The frequency of subnormal hypoosmotic swelling tests doubles in males aged 45-45.9 and quadruples in males ≥ 50 vs ≤ 34.
 
Intracytoplasmic sperm injection completely negates the implantation problem associated with
conventional fertilization with sperm with low hypoosmotic swelling test scores as evidenced by
evaluating donor-recipient pairs
21
J.H. Check, B. Katsoff, W. Yuan, D. Summers-Chase, W. Hourani, D. Horwath - Camden, NJ (USA)
Evaluating matched pairs shows that ICSI overcomes the embryo implantation potential of embryos fertilized by sperm with
low HOS scores.
 
Pregnancy outcome following fresh vs frozen embryo transfer into gestational carriers using a simplified
slow freeze protocol
23
J.H. Check, B. Katsoff, C. Wilson, J.K. Choe, D. Brasile - Camden, NJ (USA)
Live delivered pregnancy rates are 50% higher with fresh vs frozen thawed embryo transfer into gestational carriers.
 
The majority of males with subnormal hypoosmotic test scores have normal vitality 25
A. Bollendorf, J.H. Check, D. Kramer - Camden, NJ (USA)
Only 12.5% of males with low hypoosmotic swelling (HOS) tests have low vitality tests and thus they are not interchangeable.
 
General Section  
Immune response and immunotherapy in intraepithelial and invasive lesions of the uterine cervix 27
F.A. Machado, J.Ph. Janssens, M.A. Michelin, E.F.C. Murta - Uberaba, MG (BRAZIL)
Immunotherapy has the potential to be the most specific treatment for tumors including cervical intraepithelial neoplasia.
 
Severe hepatocellular dysfunction in obstetric cholestasis related to combined genetic variation in
hepatobiliary transporters
32
V. Zimmer, M. Krawczyk, M. Mahler, S.N. Weber, R. Müllenbach, F. Lammert - Homburg, GERMANY
An exceptional co-inheritance of three hepatobiliary transporter variants in ABCB4, ABCB11 and ABCG5/8 in obstetric
cholestasis is reported.
 
The effects of benzoylecgonine, oxytocin, ritodrine and atosiban on the contractility of myometrium.
An experimental study
36
N. Nikolettos, I. Triantafillidis, V. Karachaliou, G. Koutsougeras, I. Vakalopoulos - Thessaloniki, GREECE
The use of ritodrine seems to be preferable for the treatment of myometrial contractions induced by cocaine metabolites.
 
Regulation of interleukin-1 and tumor necrosis factor- -induced interleukin-8 production by amnionderived
(WISH) cells
43
Y. Kawano, Y. Furukawa, S. Karakida, N. Kira, T. Ishii, H. Narahara - Oita, JAPAN
IL-8 production regulated by cytokines in amniotic cells.
 
The efficacy of paracetamol versus tenoxicam on postoperative pain and morphine consumption
after abdominal hysterectomy: a placebo-controlled, randomized study
49

I. Gunusen, S. Karaman, A. Acar, A. Sargin, V. Firat - Izmir, TURKEY
The analgesic effects of paracetamol and tenoxicam combined with morphine were compared after elective abdominal hysterectomy.
Tenoxicam provided reliable analgesia and reduced opioid-related side-effects.

 
Malignant disease as a risk factor for surgical site infection 53
S. Kadija, A. Stefanovic´, K. Jeremic´, J. Tavcˇar, R. Argirovic´, S. Pantovic´ - Belgrade, SERBIA
A retrospective study demonstrated that advanced stages of malignant disease are important risk factors for SSI with a relative
risk of 4 and 5, respectively.
 
The trend of VEGF-A and PlGF in pregnant patients: a perspective case-control study on 214 women 57
T.S. Patrelli, S. Gizzo, M. Plebani, D. Basso, G. Capobianco, C. Bartolucci, A. Bacchi Modena,
M. Rondinelli, G.B. Nardelli - Parma, ITALY
Vascular growth factors: a new role for VEGF-A and PIGF in Clinical Obstetrics?
 
Immunohistochemical changes of adenomyosis after heat therapy: comparison of radiofrequency
myolysis and endoablation
65
H.H. Cho, Y.H. Song, M.R. Kim, S.J. Hwang, J.H. Kim - Seoul, KOREA REPUBLIC
Direct heat therapy is more effective than endometrial ablation in adenomyosis.
 
Risk factors and prevalence of urinary incontinence in postmenopausal women living in Turkey 69
S. Senturk, M. Kara - Yozgat, TURKEY
BMI, parity, vaginal delivery, advanced age and non use of HRT were detected as significant risk factors for women.
 
Comparison of propofol/ketamine versus propofol/alfentanil for dilatation and curettage 72
L. Sahin, M. Sahin, O. Aktas, E. Kilic, E. Mandollu - Kahramanmaras, TURKEY
Clinical efficacy of ketamine and alfentanil when combined with propofol for short-lasting anesthesia during D&C.
 
Removal of uterine fibroids during cesarean section: a difficult therapeutic decision 76
Y. Simsek, S. Celen, N. Danisman, L. Mollamahmutog˘lu - Ankara, TURKEY
Effects of myoma excision performed during cesarean operation on obstetrical outcome were analyzed in a controlled fashion.
 
The impact of HPV diagnosis on women’s sexual and mental health: preliminary findings 79
F. Ferenidou, N. Salakos, N. Vaidakis, G. Paltoglou, K. Bakalianou, G. Papadimitriou, G. Creatsas - Athens,
GREECE
HPV diagnosis has an important impact on emotional and physical well being, as well as psychosexual health of women.
 
Magnetic resonance hysterosalpingography in the evaluation of tubal patency in infertile women: an
observational study
83
C. De Felice, F. Rech, A. Marini, A. Stagnitti, F. Valente, V. Cipolla, G. Borgogni, M.L. Meggiorini - Rome, ITALY
The ability of magnetic resonance hysterosalpingography (MR-HSG) to demonstrate fallopian tube patency in infertile women.
 
Effects of methylene blue, pentoxyphylline and enoxaparin on postoperative adhesion formation and
markers of angiogenesis in a rat uterine horn model
89
A. Boztosun, A. Pıçak, M.I. Kosar, S. Gulturk, A. Cetin - Sivas, TURKEY
Methylene blue may prevent postoperative adhesions by the inhibition of angiogenesis.
 
Molecular diagnosis of CMV infection in fetal aborted tissues in the region of Thrace 96
I. Grammatikopoulou, M. Lambropoulou, E. Chatzaki, T.-E. Deftereou, V. Lambropoulou, M. Simopoulou,
E. Papadopoulos, G. Galazios, Th. Dimitriou, A. Petrou, N. Papadopoulos - Alexandroupolis, GREECE
The molecular study of CMV infection in 143 fetal aborted tissues, indicated a 1.4% incidence.
 
Examination of the effect of melatonin use in Pomeroy method of tubal ligation on ovarian histology
in rats
103
A.Ç. Altungül, A. Kale, E. Sapmaz, N. Akpolat - Malatya, TURKEY
The left pomeroy method of tubal ligation reduces regression of angiogenesis in the corpus luteum, and increases atretic follicle
and fibrosis development. Melatonin use can restore these harmful effects.
 
Effect of fibrin glue and comparison with suture on experimental induction of endometriosis in a rat
endometrial autograft model
107
A. Boztosun, H. Özer, R. Atılgan, G. Açmaz, T. Yalta, I · .I·. Müderris, A. Yanık - Malatya, TURKEY
Endometriosis-like lesions can be obtained by FG in animal models.
 
Comparison of diclofenac sodium with indomethacin suppositories for mediolateral episiotomies 112
A.Ç. Altungül, E. Sapmaz, A. Kale - Adana, TURKEY
Diclophenac sodium suppositories have more effective analgesia than indomethacin suppositories after mediolateral episiotomies
in early and late terms.
 
CASE REPORTS  
Early abdominal pregnancy with an unexpected and misleading location. The ultrasonographic
interpretation
115
M. Simões, C. Marques, F. Ribeiro, C. Guerreiro, I. Grilo, D. Rosa - Lisboa, PORTUGAL
A case of an early primary implantation abdominal pregnancy with a misleading and unexpected location is described.
 
First trimester diagnosis of 13q-syndrome associated with increased fetal nuchal translucency thickness.
Clinical findings and systematic review
118
E. Manolakos, P. Peitsidis, A. Garas, A. Vetro, M. Eleftheriades, M.B. Petersen, I. Papoulidis - Athens,
GREECE
Diagnosis of 13q-syndrome demonstred that CGH-arry is a precise diagnostic tool which can complete with traditional methods
for prenatal chromosomal detection.
 
Complicated abdominal hysterectomy subsequent to uterine embolization for large fibroids 122

I. Korkontzelos, N. Gkioulekas, C. Stamatopoulos, A. Magos - London, UK
A case of a complicated hysterectomy due to strong adhesions found intraabdominally most probably created by tissue necrosis
of the fibroids after UAE.

 
Removal of a large bizarre uterine leiomyoma by operative hysteroscopy. Case report and review of the
literature
124
O. Gregoriou, C. Grigoriadis, V.E. Hatzidakis, S. Mantzavinos, A. Kondi-Pafiti - Athens, GREECE
Study of a case of bizarre uterine leiomyoma removed by operative hysteroscopy and literature review.
 
Pancreatic cancer with liver metastases in a pregnant patient: case report and review of the literature 127
R. Marci, G. Pansini, C. Zavatta, E. Mossuto, E. Giugliano, M. Marzola, A. Patella - Ferrara, ITALY
Case of malignant pancreatic tumor in pregnancy is reffered.
 
Huge endometriosis presenting like an ovarian tumor: CT appearance 237
H. Yerli, N. Askar, O. Zekioglu, Z. Baglan, N. Elmas - Izmir, TURKEY
The problematic differential diagnosis between endometriosis and ovarian tumor is discussed.
 
ERRATA - CORRIGE  
Infectious respiratory diseases in pregnancy - results of a 15-year study in Seoul
Joo Yeon Cheung, Sung Shine Shim, Yookyung Kim
Vol. XXXVIII, n. 4, 2011, page 351
Errata: Department of Radiology, Mokdong Hospital, Ewha Woman’s University School of Medicine, Seoul (Korea)
Corrige: Department of Radiology, Mokdong Hospital, Ewha Womans University School of Medicine, Seoul (Korea)
 
ERRATA - CORRIGE  
Evaluation of clinical and cytogenetic fındings on 1,068 second-trimester amniocenteses in Southeast Turkey
M. Balkan, H. Akbas, S. Kalkanli, M. Erdemog˘lu, M. Fidanboy, M.N. Alp, T. Budak
Vol. XXXVIII, n. 4, 2011, page 311
Errata: M. Balkan, H. Akbas, S. Kalkanli, M. Erdemog˘lu, M. Fidanboy, M.N. Alp, T. Budak
Corrige: M. Balkan, H. Akbas, S. Kalkanli, M.N. Sakar, M. Fidanboy, M.N. Alp, T. Budak